Accessibility settings

This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (730) Non-randomized Protocols and Methods (ehealth) (716) Methods and Feasibility Studies (516) Statistical Methods (31) Immunology, Allergy, Rheumatology (153)

Published on in Vol 15 (2026)

This is a member publication of University of Cambridge (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/81415, first published .
Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study

Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study

Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study

Authors of this article:

David R W Jayne1 Author Orcid Image ;   Raashid Luqmani2 Author Orcid Image ;   Benjamin Terrier3 Author Orcid Image ;   Achim Obergfell4 Author Orcid Image ;   Charlotte Pollet4 Author Orcid Image ;   Marie Boff5 Author Orcid Image ;   Monica Balcells-Oliver4 Author Orcid Image ;   Bernhard Hellmich6 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics

David R W Jayne   1 , MD, MBChB ;   Raashid Luqmani   2 , MD, MBBS ;   Benjamin Terrier   3 , MD, PhD ;   Achim Obergfell   4 , MD, MBA, PhD ;   Charlotte Pollet   4 , MSc ;   Marie Boff   5 , MSc ;   Monica Balcells-Oliver   4 , MSc ;   Bernhard Hellmich   6 , MD

1 Department of Medicine, University of Cambridge, Cambridge, United Kingdom

2 Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom

3 Service de Médecine Interne, Hôpital Cochin, Paris, France

4 Department of Global Medical Affairs, CSL Vifor, Glattbrugg, Switzerland

5 Department of Biostatistics, CSL Vifor, Glattbrugg, Switzerland

6 Medius Kliniken, University of Tübingen, Kirchheim unter Teck, Germany

Corresponding Author:

  • David R W Jayne, MD, MBChB
  • Department of Medicine
  • University of Cambridge
  • Addenbrooke's Hospital, Hills Road
  • Cambridge CB2 2QQ
  • United Kingdom
  • Phone: 44 75402000020
  • Email: dj106@cam.ac.uk